TFS Chemicals - Aspire
Pharma Focus America
Sino Biological - Cytokine

PharmaLogic Reveals Plans for Radiopharmaceutical Production Facility in New York City

Tuesday, May 14, 2024

PharmaLogic Holdings Corp., a prominent contract development and manufacturing organization (CDMO) and radiopharmacy solutions provider, is celebrating the inauguration of its new radiopharmaceutical production and research facility in the Bronx, New York. Acquired in 2022, the facility has undergone extensive renovations and is now equipped with state-of-the-art technology, demonstrating PharmaLogic's substantial investment in advancing the development of novel radiopharmaceuticals in the region.

PharmaLogic, expressed pride in the unveiling of the new facility, stating, "Our state-of-the-art facility signifies a crucial leap in our dedication to enhancing patient care. Beyond ensuring a steady supply of essential radiopharmaceuticals for the community, the Bronx facility serves as a launchpad for promising new radio-ligand diagnostic and therapeutic drugs, ultimately bringing transformative treatments to patients."

The Bronx facility solidifies PharmaLogic's standing as a key player in the radiopharmaceutical market. This investment underscores the company's commitment to improving patient access to clinically significant radiopharmaceuticals while also driving the development of next-generation compounds. With its advanced production and laboratory capabilities, PharmaLogic aims not only to expand current production but also to allocate substantial resources to researching and developing groundbreaking new radiopharmaceuticals.

PharmaLogic emphasized the strategic importance of this investment in enhancing production and research capabilities. "Our steadfast commitment to advancing molecular imaging and theranostics is reinforced by this investment," he stated. "Through the development and delivery of innovative radiopharmaceuticals, we aim to equip the medical community with state-of-the-art diagnostic and therapeutic tools, ultimately leading to significant improvements in patient care."

 

Source: prnewswire.com

patheon - Mastering API production at every scaleWorld Vaccine Congress Europe 2024World Orphan Drug Congress 2024Future Labs Live USA 2024patheon - Revolutionizing PharmaHealthcare CNO SummitHealthcare CMO Summit